Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00636155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00563290. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b)
ClinicalTrials.gov study NCT01998880. IPD Sharing: Not stated. Countries: 26. Publications: 0.
RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05405309. IPD Sharing: NO. Countries: 1. Publications: 0.
Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome
ClinicalTrials.gov study NCT06676033. IPD Sharing: YES. Countries: 1. Publications: 0.
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01096992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT00254163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01980888. IPD Sharing: YES. Countries: 13. Publications: 0.
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00816595. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT00290407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00860457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06644183. IPD Sharing: YES. Countries: 1. Publications: 0.
Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)
ClinicalTrials.gov study NCT00364286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT05479994. IPD Sharing: YES. Countries: 1. Publications: 0.
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00602459. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status
ClinicalTrials.gov study NCT01283386. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04447768. IPD Sharing: YES. Countries: 1. Publications: 0.
A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00754650. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)
ClinicalTrials.gov study NCT01580228. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01269385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.